Kurin, a leader in innovative blood culture collection technology, is celebrating a longstanding partnership with Crouse Hospital. This collaboration marks a new era in clinical advancements, aiming ...
SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...
The accurate detection of bloodstream infections is central to effective patient management, yet false‐positive results from blood culture contamination continue to impose significant clinical and ...
Deferring antibiotic initiation until blood culture results are available is not linked to worse mortality or clinical ...
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin ® blood culture collection sets, announced that Chief Judge Connolly of the U.S. District Court for the District of ...
Rates of routine blood culture (BC) testing for uncomplicated infections in children had no significant effect on length of stay, costs, return emergency department visits, or hospital readmissions, ...
SEATTLE, July 29, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the inventor of the Steripath® Initial Specimen Diversion Device® platform, today announced the appointment of Jason Richey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback